*Department of Ophthalmology, Jewish General Hospital, McGill University, Montreal, QC †Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.
J Glaucoma. 2014 Sep;23(7):430-4. doi: 10.1097/IJG.0b013e31827b139d.
Our goal is to investigate the opinion and practice pattern of Canadian ophthalmologists regarding the use of and recommendations for complementary and alternative medicine (CAM) for their glaucoma patients.
Institutional review board approval for this prospective, cross-sectional survey was obtained from the Research Ethics Board of Sunnybrook Health Sciences Centre. The survey was sent to all ophthalmologists in Canada electronically through the e-mail lists of 4 ophthalmology associations.
A total of 241 ophthalmologists representing all provinces in Canada responded to the questionnaire. Twenty-two percent felt that CAM does have a role in glaucoma therapy with specialists being more likely to believe there is a role (P<0.05). Of the total respondents, 26% ask their patients if they use CAM with those in practice for <20 years more likely to encourage use (P<0.05). Of the respondents, 9% recommend CAM and if an ophthalmologist was in practice for <20 years he/she was significantly more likely to recommend CAM (P<0.01). Respondents (62%) in general do not discourage CAM with younger ophthalmologists (younger than 50 y, P<0.02) and ophthalmologists in practice for <20 years (P<0.05) being less likely to discourage CAM use. Respondents (41%) believe that CAM rarely ever affects compliance with ophthalmologists from an urban practice (P<0.01) and academic practice (P<0.05) more likely to deny effect on compliance. Respondents believe that CAM sometimes (46%) results in patient morbidity with ophthalmologists being in practice for <20 years believing that morbidity is less likely (P<0.05).
A substantial minority of respondents believe that CAM has a role in glaucoma therapy, recommend its use, and ask their patients if they use CAM. Younger doctors are more likely to encourage alternatives; those in practice for <20 years are more likely to ask about alternative medicine use, recommend its use, and believe that morbidity usually does not result from the use of alternative treatments.
我们的目标是调查加拿大眼科医生对使用和推荐补充和替代医学(CAM)治疗青光眼患者的看法和实践模式。
通过电子邮件列表向加拿大 4 个眼科协会的所有眼科医生发送了这项前瞻性、横断面调查的问卷。从 Sunnybrook 健康科学中心的研究伦理委员会获得了这项调查的机构审查委员会批准。
共有 241 名代表加拿大所有省份的眼科医生对问卷做出了回应。22%的人认为 CAM 在青光眼治疗中确实有作用,专家更有可能认为有作用(P<0.05)。在所有回答者中,26%的人会询问患者是否使用 CAM,而那些从业时间不到 20 年的医生更有可能鼓励患者使用(P<0.05)。在回答者中,9%的人推荐 CAM,而从业时间不到 20 年的医生更有可能推荐 CAM(P<0.01)。一般来说,年轻的眼科医生(小于 50 岁)和从业时间不到 20 年的医生(P<0.02)不太可能劝阻患者使用 CAM,这表明眼科医生更倾向于不劝阻 CAM 的使用。41%的受访者认为 CAM 很少会影响到来自城市实践(P<0.01)和学术实践(P<0.05)的眼科医生的依从性。受访者认为 CAM 有时(46%)会导致患者出现发病率,而从业时间不到 20 年的医生则认为发病率较低(P<0.05)。
相当一部分受访者认为 CAM 在青光眼治疗中有一定的作用,建议使用,并且会询问患者是否使用 CAM。年轻医生更有可能鼓励替代疗法;从业时间不到 20 年的医生更有可能询问替代疗法的使用情况、建议使用,并认为使用替代疗法通常不会导致发病率增加。